Retail recovery helps Boots offset slump in pharmacy sales
It came as impairment charges for the UK operation helped drag its US parent firm Walgreens Boots Alliance (WBA) to a significant loss.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Boots has revealed a further boost from high street and travel stores helped to offset declines in the firm’s pharmacy business.
It came as impairment charges for the UK operation helped drag its US parent firm Walgreens Boots Alliance (WBA) to a significant loss in the fourth quarter of its financial year.
WBA told investors on Thursday that it suffered loss per share of 48 cents for the three months to August, slipping from a profit a year earlier.
The group said it came after the Boots business was hit by a 783 million dollar (£695.5 million) non-cash impairment.
It came as WBA reported that it saw like-for-like sales tumble 5.3% to 32.4 billion dollars (£32.8 billion) over the quarter, driven by declines at its US pharmacy operation.
In the UK, Boots revealed that retail sales grew by 15.2% over the three months to August, with trade recovering beyond pre-pandemic levels.
The retailer benefited from returning customers at city centres, airports and train stations.
Boots added that it witnessed surging sales of sunscreen amid the summer heatwave while the business also benefited from new beauty brand releases.
However, Boots pharmacy sales declined by 6.9% over the same quarter last year as it struggled to keep up with a Covid-buoyed performance.
Sebastian James, managing director of Boots UK & ROI, said: “This is a really encouraging set of results.
“I am especially happy to see more and more customers choosing Boots over others and our market share rising as a result.
“In addition, I am pleased with the progress we are making in quickly introducing new, trending beauty brands, our healthcare services supporting the NHS and, of course, with our boots.com offer, which is now double its pre-pandemic levels.”